Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jihei Sara Lee & Chan Yun Kim. (2022) Brimonidine tartrate ophthalmic solution 0.025% for redness relief: an overview of safety and efficacy. Expert Review of Clinical Pharmacology 15:8, pages 911-919.
Read now
Read now
Lester O Hosten & Christopher Snyder. (2020) Over-the-Counter Ocular Decongestants in the United States – Mechanisms of Action and Clinical Utility for Management of Ocular Redness. Clinical Optometry 12, pages 95-105.
Read now
Read now
Articles from other publishers (9)
José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Etty Bitton, Wei Chen, Farhad Hafezi, Pedram Hamrah, Ruth E. Hogg, Jutta Horwath-Winter, Georgios A. Kontadakis, Jodhbir S. Mehta, Elisabeth M. Messmer, Victor L. Perez, David Zadok & Mark D.P. Willcox. (2023) TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface. The Ocular Surface 29, pages 331-385.
Crossref
Crossref
Marissa K. Shoji, Zahra Markatia, Kambiz Ameli, Mandah Bayaraa, Kevin D. Clauss, Shoaib Ugradar & Wendy W. Lee. (2023) The effects of topical oxymetazoline on eyelid position, eye redness, and patient-reported eye appearance: A randomized controlled trial. Journal of Plastic, Reconstructive & Aesthetic Surgery 80, pages 66-74.
Crossref
Crossref
Fikret Ucar & Halil İbrahim Yener. (2022) Can bleeding in trabeculectomy be decreased? Effectiveness of brimonidine pre-treatment. European Journal of Ophthalmology 32:6, pages 3476-3481.
Crossref
Crossref
Shudan Wang, Lingjia Liu, Tomas Blanco, Hongyan Ge, Yutong Xia, Kunpeng Pang, Yihe Chen & Reza Dana. (2022) Therapeutic efficacy of topical blockade of substance P in experimental allergic red eye. The Ocular Surface 26, pages 184-190.
Crossref
Crossref
Rohan Bir Singh, Lingjia Liu, Ann Yung, Sonia Anchouche, Sharad K. Mittal, Tomas Blanco, Thomas H. Dohlman, Jia Yin & Reza Dana. (2021) Ocular redness – II: Progress in development of therapeutics for the management of conjunctival hyperemia. The Ocular Surface 21, pages 66-77.
Crossref
Crossref
Mari Carmen Desco, Julio Cesar Molina Martín, Jorge Mataix-Boronat, Isabel Pascual-Camps, Elena Palacios-Pozo, Marisa Barón-García, David P Piñero & Amparo Navea-Tejerina. (2021) Prophylactic effect of brimonidine to minimize the incidence of subconjunctival hemorrhage in the early postoperative period after 23G pars plana vitrectomy. Therapeutic Advances in Ophthalmology 13, pages 251584142110457.
Crossref
Crossref
N Cimolai. (2020) A review of neuropsychiatric adverse events from topical ophthalmic brimonidine. Human & Experimental Toxicology 39:10, pages 1279-1290.
Crossref
Crossref
O. N. Onufriichuk, I. R. Gazizova, A. V. Kuroyedov & A. V. Seleznev. (2020) The effect of the main active substances of antihypertensive eye drops on condition of the eyes of glaucoma patients. Pacific Medical Journal:3, pages 5-10.
Crossref
Crossref
Nofar Kimchi & Leonard Bielory. (2020) The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents. Current Opinion in Allergy & Clinical Immunology 20:4, pages 414-420.
Crossref
Crossref